{"cik":1719714,"taxonomy":"us-gaap","tag":"CurrentIncomeTaxExpenseBenefit","label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","entityName":"MEREO BIOPHARMA GROUP PLC","units":{"USD":[{"start":"2022-01-01","end":"2022-12-31","val":718000,"accn":"0000950170-24-037348","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-27","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":532000,"accn":"0000950170-24-037348","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-27"},{"start":"2023-01-01","end":"2023-12-31","val":532000,"accn":"0000950170-25-044787","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-26","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":0,"accn":"0000950170-25-044787","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-26","frame":"CY2024"}]}}